Insider Transactions in Q1 2018 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q1 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.72%
|
$300,000
$12.93 P/Share
|
|
Feb 02
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,840
+1.09%
|
$529,760
$14.73 P/Share
|
|
Feb 01
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,840
+0.67%
|
$319,760
$14.99 P/Share
|
|
Jan 31
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
339,400
+9.17%
|
$5,091,000
$15.0 P/Share
|
|
Jan 29
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.63%
|
$700,000
$14.99 P/Share
|
|
Jan 26
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,760
+0.76%
|
$318,640
$14.93 P/Share
|
|
Jan 24
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
64,637
+2.14%
|
$904,918
$14.91 P/Share
|
|
Jan 23
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,363
+0.15%
|
$61,082
$14.99 P/Share
|
|
Jan 22
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
75,000
+2.54%
|
$1,050,000
$14.98 P/Share
|
|
Jan 19
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
74,931
+2.6%
|
$1,049,034
$14.95 P/Share
|
|
Jan 12
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
66,800
+1.22%
|
$935,200
$14.95 P/Share
|
|
Jan 11
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
41,700
+1.54%
|
$542,100
$13.65 P/Share
|
|
Jan 10
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
170,338
+6.1%
|
$2,044,056
$12.83 P/Share
|